JNJ vs RMD
By Alex · Tickerpine
Johnson & Johnson vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | RMD |
|---|---|---|
| Price | $260.86 | $226.00 |
| Market cap | $628.65B | $32.78B |
| P/E ratio | 30.3 | 21.5 |
| ROE | 25.74% | 24.27% |
| Profit margin | 21.48% | 26.95% |
| Revenue growth | 6.60% | 8.60% |
| Dividend yield | 2.05% | 1.17% |
| Beta | 0.23 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs RMD in plain English
- JNJ is the bigger company — about 19.2× the market cap of RMD.
- RMD is cheaper on earnings (P/E 21.5 vs 30.3).
- JNJ earns a higher return on equity (26% vs 24%).
- RMD is growing revenue faster (9% vs 7%).
- JNJ has the higher dividend yield (2.05% vs 1.17%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.